MLR

Potency Assays and Release Testing of CAR T-Cell Therapies

CAR T-cell therapy represents a significant shift in the treatment landscape for cancer, particularly in hematologic malignancies. Unlike traditional immunotherapies, Chimeric Antigen Receptor (CAR) T-cells are genetically engineered T lymphocytes that can recognize specific tumor antigens independently of the major histocompatibility complex (MHC). After being redirected to identify cancer cells through an extracellular antigen-binding domain, […]

Recent Articles​

Inhaler-Based Immunotherapy for Lung Cancer
Anti-Viral Therapy

Inhaler-Based Immunotherapy for Lung Cancer

Lung cancer is among the most lethal malignancies worldwide, with limited therapeutic success despite advancements in immunotherapy. Immune checkpoint inhibitors (ICIs), particularly those targeting PD-1/PD-L1 pathways, have marked a paradigm

Read More »

Recent Articles